Repligen | RGEN - Заемный капитал





Заемный капитал Изменить Дата
Agilent USD 3.64B 594M 2026-06
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Bruker USD 1.81B 151.8M 2026-06
Charles River Laboratories USD 2.62B 43.15M 2026-06
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2B 10M 2026-06
General Electric Aerospace USD 17.16B 1.02B 2026-06
Henry Schein USD 2.3B 27M 2026-06
Illumina USD 1.49B 1000K 2026-06
IQVIA Holdings USD 13.7B 284M 2026-06
Mettler Toledo International USD 2.04B 116.92M 2026-06
Myriad Genetics USD 120.7M 400K 2026-06
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pfizer USD 60.5B 70M 2026-06
Repligen USD 551.05M 4.46M 2026-06
Revvity USD 2.63B 1.02M 2026-06
Standard Biotools USD 299K 0 2026-03
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Waters USD 5.09B 129M 2026-06
West Pharmaceutical Services USD 202.9M 100K 2026-06